Renovion is a clinical stage pharmaceutical company with a nebulized therapy that restores mucus clearance and reduces inflammation in the lungs. We are focused on developing ARINA-1 for orphan chronic inflammatory lung diseases.  

With over 25 patient years of experience, ARINA-1 is poised to start clinical studies in lung transplant, cystic fibrosis (CF) and non-CF bronchiectasis.